{"id":1000751,"date":"2026-09-04T11:08:57","date_gmt":"2026-09-04T15:08:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/"},"modified":"2026-09-04T11:08:57","modified_gmt":"2026-09-04T15:08:57","slug":"uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/","title":{"rendered":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Sept.  04, 2026  (GLOBE NEWSWIRE) &#8212;  A shareholder class action lawsuit has been filed against Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d) (NASDAQ: UNCY). The lawsuit alleges that Defendants made false and misleading statements and\/or failed to disclose material adverse facts, including allegations that: (1) Unicycive had not inspected its third-party manufacturing vendor\u2019s facility or otherwise audited the facility\u2019s compliance with current good manufacturing practices; (2) as a result, Unicycive lacked a reasonable basis to believe that the vendor had resolved the FDA\u2019s cited deficiencies; (3) there was an undisclosed risk that the FDA would require additional information about the vendor\u2019s facility\u2019s manufacturing practices; (4) as a result of the foregoing, the regulatory approval of oxylanthanum carbonate was reasonably likely to be delayed; and (5) as a result of the foregoing, Defendants\u2019 positive statements about Unicycive\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p align=\"justify\">If you purchased Unicycive shares between <strong>December 29, 2025 and June 29, 2026,<\/strong>\u00a0and experienced a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5iHKHbiDKig9EBNqsIPGlnZwVmgrRJBJq3dO5loxRWP8pXhFRf8gv-m6CPq4saiyt4LuOYg45YzIhAz0tntf0Jatfo7ObXMfU9TJaXCu3kk=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TN9cAGBNzZT8KrOICy0cHmGlbZU5XzSAIC9xVuItGJPURZ_sEAElZdWrVQpVFnakUw_ksKmtBugK6YnyhuAFjF5nl1JAxZQEMkTV3kLHzM6NaHrvd4ZlCwbQTZzf9eQV3Uef4ovmIIKV_M4x6eurtK60_gSjtS9HVvGFtHIXTS4=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/unicycive-therapeutics\/<\/a>\u00a0for more information.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is November 2, 2026.\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202fwww.holzerlaw.com,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey D. Holzer, Esq. <br \/>(888) 508-6832 (toll-free)<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5iHKHbiDKig9EBNqsIPGlnZwVmgrRJBJq3dO5loxRWP1oKSK_c2-PM_N5jUMtjcUAdFaFJhOqquzTF4-LH5apiHRmmrQw1KIYdR6J-tzEbE=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzQ4MzgyYTUtMWVjZi00ZmRmLWFjMDUtNTcwYjJkYTQxMzNkLTExOTIzMzYtMjAyNi0wOS0wNC1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d) (NASDAQ: UNCY). The lawsuit alleges that Defendants made false and misleading statements and\/or failed to disclose material adverse facts, including allegations that: (1) Unicycive had not inspected its third-party manufacturing vendor\u2019s facility or otherwise audited the facility\u2019s compliance with current good manufacturing practices; (2) as a result, Unicycive lacked a reasonable basis to believe that the vendor had resolved the FDA\u2019s cited deficiencies; (3) there was an undisclosed risk that the FDA would require additional information about the vendor\u2019s facility\u2019s manufacturing practices; (4) as a result of the foregoing, the regulatory approval of oxylanthanum carbonate was reasonably likely to be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000751","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d) (NASDAQ: UNCY). The lawsuit alleges that Defendants made false and misleading statements and\/or failed to disclose material adverse facts, including allegations that: (1) Unicycive had not inspected its third-party manufacturing vendor\u2019s facility or otherwise audited the facility\u2019s compliance with current good manufacturing practices; (2) as a result, Unicycive lacked a reasonable basis to believe that the vendor had resolved the FDA\u2019s cited deficiencies; (3) there was an undisclosed risk that the FDA would require additional information about the vendor\u2019s facility\u2019s manufacturing practices; (4) as a result of the foregoing, the regulatory approval of oxylanthanum carbonate was reasonably likely to be &hellip; Continue reading &quot;UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-04T15:08:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0\",\"datePublished\":\"2026-09-04T15:08:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/\"},\"wordCount\":358,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/\",\"name\":\"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\",\"datePublished\":\"2026-09-04T15:08:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk","og_description":"ATLANTA, Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d) (NASDAQ: UNCY). The lawsuit alleges that Defendants made false and misleading statements and\/or failed to disclose material adverse facts, including allegations that: (1) Unicycive had not inspected its third-party manufacturing vendor\u2019s facility or otherwise audited the facility\u2019s compliance with current good manufacturing practices; (2) as a result, Unicycive lacked a reasonable basis to believe that the vendor had resolved the FDA\u2019s cited deficiencies; (3) there was an undisclosed risk that the FDA would require additional information about the vendor\u2019s facility\u2019s manufacturing practices; (4) as a result of the foregoing, the regulatory approval of oxylanthanum carbonate was reasonably likely to be &hellip; Continue reading \"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-04T15:08:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0","datePublished":"2026-09-04T15:08:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/"},"wordCount":358,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/","name":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=","datePublished":"2026-09-04T15:08:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTY4NyM3ODE4ODM0IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uncy-investor-alert-class-action-lawsuit-filed-on-behalf-of-unicycive-therapeutics-inc-investors-holzer-holzer-llc-encourages-investors-with-losses-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UNCY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics, Inc. Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Losses to Contact the Firm\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000751"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000751\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}